Patients in U.S. Clinical Trials Injected with 150,000 human embryonic stem cell- derived Retinal Pigment Epithelial Cells )--Advanced Cell Technology, Inc.
http://eon.businesswire.com/news/eon/20130401005344/en/ACT-Initiates-Treatment-Higher-Dosage-Cohort-Clinical-Trials
http://eon.businesswire.com/news/eon/20130401005344/en/ACT-Initiates-Treatment-Higher-Dosage-Cohort-Clinical-Trials
No comments:
Post a Comment